Skip to main
SIBN
SIBN logo

SI-BONE Inc (SIBN) Stock Forecast & Price Target

SI-BONE Inc (SIBN) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

SI-BONE Inc. has demonstrated strong financial performance in the second quarter of 2025, with a gross margin increase of approximately 80 basis points year-over-year, reaching 79.8%. The company also reported a significant revenue growth of around 23% year-over-year, totaling $46.4 million, indicating strong demand for its medical devices. Additionally, the increase in surgeon utilization, up roughly 25% year-over-year, further highlights the effectiveness of its sales strategy and the growing acceptance of its proprietary surgical implant systems.

Bears say

The analysis of SI-BONE Inc. indicates several fundamental challenges impacting its stock outlook. The global spine market has recently faced pricing pressures and procedural headwinds, resulting in slowed growth to low single digits, which could hinder SI-BONE's expansion prospects. Furthermore, the potential for payors to favor competitive products for reimbursement threatens to erode SI-BONE's market share in the sacroiliac joint fusion area, significantly affecting the company’s revenue potential amid an expected continuation of market headwinds.

SI-BONE Inc (SIBN) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SI-BONE Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SI-BONE Inc (SIBN) Forecast

Analysts have given SI-BONE Inc (SIBN) a Buy based on their latest research and market trends.

According to 4 analysts, SI-BONE Inc (SIBN) has a Buy consensus rating as of Nov 1, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $25.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $25.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SI-BONE Inc (SIBN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.